Purchase Order 36C24226P0260
Award Date 12/29/25
Potential Completion Date 1/5/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for the provision of TARPEYO medication, valued at $10,896.98. This contract, awarded on November 4, 2025, carries an ultimate completion date of December 31, 2025, and includes no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania, where the prime contractor is...
- Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, was awarded a firm fixed-price purchase order valued at $10,896.98 by Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs. The award, dated October 30, 2025, covers the supply of Tarpeyo 4mg (budesonide), a specialty pharmaceutical product, with performance occurring in Pittsburgh, Pennsylvania and ultimate completion targeted for November 30, 2025. No set-aside...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a $10,896.98 firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on October 15, 2025, for the supply of TARPEYO 4mg (budesonide) to support the Margaret Cochran Corbin Veterans Medical Center at the New York Harbor. Pantherx Specialty, a Pittsburgh-based pharmaceutical company and subsidiary of Centene Corporation, specializes in rare disease...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency provision of TARPEYO 4mg prescription medication, with a ceiling value of $10,896.98 and a performance period ending on November 2, 2025. The contract was awarded on October 2, 2025, and does not have a set-aside...
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $10,896.98, is for the supply of TARPEYO 4MG (NDC 81749-0004-01), an emergency pharmaceutical product, to the VA's Veterans Integrated Service Network (VISN) 2. The contract has an ultimate completion date of July 30, 2025. Pantherx Specialty is the prime contractor,...
- Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, was awarded a firm fixed-price purchase order valued at $10,896.98 by Veterans Integrated Service Network (VISN) 2, a civilian agency within the Department of Veterans Affairs. The contract, awarded on November 26, 2025, calls for the emergency delivery of TARPEYO (budesonide) 4mg to support the New York Harbor region, with an ultimate completion date of December 26, 2025. The Pittsburgh, Pennsylvania-based specialty...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the delivery of TARPEYO 4mg (NDC 81749-0004-01), an emergency medical product, with a ceiling value of $10,896.98 and a period of performance ending on August 13, 2025. This contract does not have a...